Harvest One Cannabis Inc. (TSX-V:HVT, OTCQB:HRVOF) said its DreamWater and LivRelief subsidiaries have signed a sales and distribution agreement with Nigeria-based distributor Pharmtick to expand their international distribution networks.
Under the agreement, Pharmtick will sell and distribute DreamWater and LivRelief products throughout Africa for a term of three years.
A leading African consumer goods distributor, Pharmtick represents brands such as Pfizer, Bayer, GlaxoSmithKline, Novartis, TEVA, Actavis, Accord and Vitabiotics. It also has a growing number of leading over-the-counter products including cold, flu, allergy, heartburn and immune booster products.
"Aligning our core brands with one of Africa's leading healthcare and wellness distributors is an important step in the continuing advancement of Harvest One's international distribution strategy," Gord Davey, president and chief executive officer of Harvest One, said in a statement.
READ: Harvest One Cannabis reaches agreements for US market expansion of its retail distribution footprint with five major National key account partners
"Global expansion is a key priority for Harvest One. Our e-commerce sales in North America have grown significantly and expanded the reach of our brands. Gaining access to additional international markets, such as Africa, is an important milestone for Harvest One. Pharmtick has access to online distribution throughout several prominent countries in Africa and we strongly believe that Pharmtick is the right partner to lead our marketing and product awareness efforts in a new continent," added Davey.
Harvest One is a global cannabis-infused CPG leader that develops and distributes premium health, wellness and self-care products with a market focus on sleep and pain. The company is uniquely positioned in the cannabis space with a focus on cannabis-infused and non-infused consumer packaged goods.
Contact the author at jon.hopkins@proactiveinvestors.com